153 related articles for article (PubMed ID: 36099097)
1. Evaluation of Real-world Data for Breast-MRI BI-RADS IV Lesions.
Hachenberg J; Steinkasserer L; Malter W; Thangarajah F; Warm M; Gossmann A; Brod M; Pahmeyer C; Eichler C
In Vivo; 2022; 36(5):2255-2259. PubMed ID: 36099097
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
[TBL] [Abstract][Full Text] [Related]
3. Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS).
Badan GM; Piato S; Roveda D; de Faria Castro Fleury E
Eur J Radiol; 2016 Oct; 85(10):1701-1707. PubMed ID: 27666605
[TBL] [Abstract][Full Text] [Related]
4. The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams.
Milos RI; Pipan F; Kalovidouri A; Clauser P; Kapetas P; Bernathova M; Helbich TH; Baltzer PAT
Eur Radiol; 2020 Nov; 30(11):6052-6061. PubMed ID: 32504098
[TBL] [Abstract][Full Text] [Related]
5. Interobserver variability and likelihood of malignancy for fifth edition BI-RADS MRI descriptors in non-mass breast lesions.
Lunkiewicz M; Forte S; Freiwald B; Singer G; Leo C; Kubik-Huch RA
Eur Radiol; 2020 Jan; 30(1):77-86. PubMed ID: 31392476
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Invasive Breast Cancer in Patients With Ductal Carcinoma In Situ in Ultrasound-Guided Core Needle Biopsy.
Shin YJ; Kim SM; Yun B; Jang M; Kim B; Lee SH
J Ultrasound Med; 2019 Feb; 38(2):481-488. PubMed ID: 30069893
[TBL] [Abstract][Full Text] [Related]
7. Automated breast ultrasound: lesion detection and BI-RADS classification--a pilot study.
Wenkel E; Heckmann M; Heinrich M; Schwab SA; Uder M; Schulz-Wendtland R; Bautz WA; Janka R
Rofo; 2008 Sep; 180(9):804-8. PubMed ID: 18704878
[TBL] [Abstract][Full Text] [Related]
8. Deep learning of mammogram images to reduce unnecessary breast biopsies: a preliminary study.
Liu C; Sun M; Arefan D; Zuley M; Sumkin J; Wu S
Breast Cancer Res; 2024 May; 26(1):82. PubMed ID: 38790005
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted imaging (b value = 1500 s/mm(2)) is useful to decrease false-positive breast cancer cases due to fibrocystic changes.
Ochi M; Kuroiwa T; Sunami S; Murakami J; Miyahara S; Nagaie T; Oya M; Yabuuchi H; Hatakenaka M
Breast Cancer; 2013 Apr; 20(2):137-44. PubMed ID: 22161277
[TBL] [Abstract][Full Text] [Related]
10. Atypical ductal hyperplasia: breast DCE-MRI can be used to reduce unnecessary open surgical excision.
Bertani V; Urbani M; La Grassa M; Balestreri L; Berger N; Frauenfelder T; Boss A; Marcon M
Eur Radiol; 2020 Jul; 30(7):4069-4081. PubMed ID: 32144463
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and Predictive Value of BI-RADS 3, 4, and 5 Lesions Detected on Breast MRI: Correlation with Study Indication.
Chikarmane SA; Tai R; Meyer JE; Giess CS
Acad Radiol; 2017 Apr; 24(4):435-441. PubMed ID: 27955878
[TBL] [Abstract][Full Text] [Related]
12. BI-RADS-MRI terminology and evaluation of intraductal carcinoma and ductal carcinoma in situ.
Tozaki M
Breast Cancer; 2013 Jan; 20(1):13-20. PubMed ID: 22109641
[TBL] [Abstract][Full Text] [Related]
13. [Stereotactic Mammotome breast biopsy: routine clinical experience and correlation with BI-RADS--classification and histopathology].
Michel SC; Löw R; Singer G; Otto R; Hohl M; Kubik RA
Praxis (Bern 1994); 2007 Sep; 96(39):1459-74. PubMed ID: 17966279
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging of the breast as a problem-solving method: to be or not to be?
Oztekin PS; Kosar PN
Breast J; 2014; 20(6):622-31. PubMed ID: 25200378
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and Outcomes of BI-RADS 3 Lesions on Breast MRI.
Panigrahi B; Harvey SC; Mullen LA; Falomo E; Di Carlo P; Lee B; Myers KS
Clin Breast Cancer; 2019 Feb; 19(1):e152-e159. PubMed ID: 30268764
[TBL] [Abstract][Full Text] [Related]
16. Retroareolar masses and intraductal abnormalities detected on screening ultrasound: can biopsy be avoided?
Guo Y; Raghu M; Durand M; Hooley R
Br J Radiol; 2018 Oct; 91(1090):20170816. PubMed ID: 29338316
[TBL] [Abstract][Full Text] [Related]
17. [The role of stereotactic 11G vacuum biopsy for clarification of BI-RADS IV findings in mammography].
Diebold T; Jacobi V; Krapfl E; von Minckwitz G; Solbach C; Ballenberger S; Hochmuth K; Balzer JO; Fellbaum M; Kaufmann M; Vogl TJ
Rofo; 2003 Apr; 175(4):489-94. PubMed ID: 12677503
[TBL] [Abstract][Full Text] [Related]
18. Impact of the Kaiser score on clinical decision-making in BI-RADS 4 mammographic calcifications examined with breast MRI.
Wengert GJ; Pipan F; Almohanna J; Bickel H; Polanec S; Kapetas P; Clauser P; Pinker K; Helbich TH; Baltzer PAT
Eur Radiol; 2020 Mar; 30(3):1451-1459. PubMed ID: 31797077
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic vacuum-assisted breast biopsy in 268 nonpalpable lesions.
Tonegutti M; Girardi V
Radiol Med; 2008 Feb; 113(1):65-75. PubMed ID: 18338128
[TBL] [Abstract][Full Text] [Related]
20. Can second-look ultrasound downgrade MRI-detected lesions? A retrospective study.
Kolta M; Clauser P; Kapetas P; Bernathova M; Pinker K; Helbich TH; Baltzer PAT
Eur J Radiol; 2020 Jun; 127():108976. PubMed ID: 32339982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]